Escalon Medical Corp. (ESMC)
USD 0.16
(-11.11%)
USD 0.16
(-11.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -104.47 Thousand USD | -121.83% |
| 2023 | 478.54 Thousand USD | 1211.54% |
| 2022 | 36.48 Thousand USD | 220.89% |
| 2021 | -30.18 Thousand USD | 4.77% |
| 2020 | -31.69 Thousand USD | 87.47% |
| 2019 | -252.95 Thousand USD | -223.56% |
| 2018 | 204.72 Thousand USD | 132.66% |
| 2017 | -626.89 Thousand USD | 45.02% |
| 2016 | -1.14 Million USD | -8.37% |
| 2015 | -1.05 Million USD | -194.31% |
| 2014 | -357.51 Thousand USD | 70.98% |
| 2013 | -1.23 Million USD | 44.86% |
| 2012 | -2.23 Million USD | 61.29% |
| 2011 | -5.77 Million USD | -70.44% |
| 2010 | -3.38 Million USD | 73.53% |
| 2009 | -12.79 Million USD | 15.41% |
| 2008 | -15.12 Million USD | -360.82% |
| 2007 | 5.79 Million USD | 290.99% |
| 2006 | -3.03 Million USD | -344.85% |
| 2005 | -682.51 Thousand USD | -120.92% |
| 2004 | 3.26 Million USD | 32.6% |
| 2003 | 2.46 Million USD | 38.08% |
| 2002 | 1.78 Million USD | 7.27% |
| 2001 | 1.66 Million USD | 189.85% |
| 2000 | -1.84 Million USD | -716.22% |
| 1999 | 300 Thousand USD | 400.0% |
| 1998 | -100 Thousand USD | 98.31% |
| 1997 | -5.9 Million USD | -37.21% |
| 1996 | -4.3 Million USD | 6.52% |
| 1995 | -4.6 Million USD | 26.98% |
| 1994 | -6.3 Million USD | -16.67% |
| 1993 | -5.4 Million USD | -35.0% |
| 1992 | -4 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -15.64 Thousand USD | -107.64% |
| 2024 Q4 | 138.3 Thousand USD | 188.31% |
| 2024 Q2 | -70.52 Thousand USD | -350.69% |
| 2024 Q3 | -156.61 Thousand USD | -122.08% |
| 2023 Q4 | 204.88 Thousand USD | -65.25% |
| 2023 Q3 | 589.55 Thousand USD | 19651566.67% |
| 2023 Q1 | -315.89 Thousand USD | -670.33% |
| 2023 Q2 | 3.00 USD | 100.0% |
| 2023 FY | 478.54 Thousand USD | 1211.54% |
| 2022 Q3 | -291.91 Thousand USD | -495.1% |
| 2022 Q1 | -184.48 Thousand USD | -199.0% |
| 2022 Q4 | 55.38 Thousand USD | 118.97% |
| 2022 FY | 36.48 Thousand USD | 220.89% |
| 2022 Q2 | -49.05 Thousand USD | 73.41% |
| 2021 Q3 | -132.22 Thousand USD | -227.44% |
| 2021 Q1 | -191.57 Thousand USD | 58.77% |
| 2021 FY | -30.18 Thousand USD | 4.77% |
| 2021 Q2 | 103.75 Thousand USD | 154.16% |
| 2021 Q4 | 186.35 Thousand USD | 240.93% |
| 2020 Q4 | -464.62 Thousand USD | -262.12% |
| 2020 Q3 | -128.3 Thousand USD | 80.93% |
| 2020 Q2 | -672.98 Thousand USD | -403.17% |
| 2020 FY | -31.69 Thousand USD | 87.47% |
| 2020 Q1 | -133.74 Thousand USD | -2473.05% |
| 2019 Q4 | -5198.00 USD | -123.43% |
| 2019 Q3 | 22.18 Thousand USD | 109.79% |
| 2019 Q2 | -226.54 Thousand USD | -422.06% |
| 2019 Q1 | -43.39 Thousand USD | -154.79% |
| 2019 FY | -252.95 Thousand USD | -223.56% |
| 2018 Q3 | -92.34 Thousand USD | -137.67% |
| 2018 Q1 | -27.27 Thousand USD | 78.22% |
| 2018 FY | 204.72 Thousand USD | 132.66% |
| 2018 Q4 | 79.2 Thousand USD | 185.77% |
| 2018 Q2 | 245.13 Thousand USD | 998.86% |
| 2017 Q2 | -42.51 Thousand USD | 88.97% |
| 2017 Q3 | -73.89 Thousand USD | -73.82% |
| 2017 Q4 | -125.21 Thousand USD | -69.46% |
| 2017 FY | -626.89 Thousand USD | 45.02% |
| 2017 Q1 | -385.27 Thousand USD | 23.52% |
| 2016 Q3 | -78.21 Thousand USD | 70.5% |
| 2016 Q2 | -265.11 Thousand USD | 9.58% |
| 2016 Q4 | -503.75 Thousand USD | -544.07% |
| 2016 Q1 | -293.2 Thousand USD | 45.96% |
| 2016 FY | -1.14 Million USD | -8.37% |
| 2015 Q3 | 7420.00 USD | 109.66% |
| 2015 FY | -1.05 Million USD | -194.31% |
| 2015 Q1 | -440.23 Thousand USD | -5.26% |
| 2015 Q2 | -76.77 Thousand USD | 82.56% |
| 2015 Q4 | -542.61 Thousand USD | -7412.83% |
| 2014 Q2 | -89.3 Thousand USD | -336.78% |
| 2014 Q3 | 112.3 Thousand USD | 225.76% |
| 2014 Q4 | -418.23 Thousand USD | -472.4% |
| 2014 FY | -357.51 Thousand USD | 70.98% |
| 2014 Q1 | 37.71 Thousand USD | 108.38% |
| 2013 Q3 | -294.86 Thousand USD | -368.98% |
| 2013 Q2 | 109.62 Thousand USD | 118.37% |
| 2013 Q1 | -596.6 Thousand USD | -62.05% |
| 2013 FY | -1.23 Million USD | 44.86% |
| 2013 Q4 | -449.95 Thousand USD | -52.6% |
| 2012 Q3 | -562.72 Thousand USD | 37.29% |
| 2012 Q4 | -368.15 Thousand USD | 34.58% |
| 2012 FY | -2.23 Million USD | 61.29% |
| 2012 Q1 | -707.9 Thousand USD | 69.19% |
| 2012 Q2 | -897.37 Thousand USD | -26.77% |
| 2011 Q2 | -824.39 Thousand USD | 2.92% |
| 2011 FY | -5.77 Million USD | -70.44% |
| 2011 Q4 | -2.29 Million USD | -27.66% |
| 2011 Q3 | -1.79 Million USD | -118.32% |
| 2011 Q1 | -849.18 Thousand USD | 51.25% |
| 2010 Q1 | -537.76 Thousand USD | 95.1% |
| 2010 Q4 | -1.74 Million USD | -659.94% |
| 2010 FY | -3.38 Million USD | 73.53% |
| 2010 Q3 | -229.21 Thousand USD | 73.88% |
| 2010 Q2 | -877.59 Thousand USD | -63.19% |
| 2009 Q4 | -10.97 Million USD | -1904.76% |
| 2009 FY | -12.79 Million USD | 15.41% |
| 2009 Q3 | -547.55 Thousand USD | 28.99% |
| 2009 Q2 | -771.09 Thousand USD | -54.85% |
| 2009 Q1 | -497.98 Thousand USD | 95.73% |
| 2008 Q2 | -705.63 Thousand USD | 20.95% |
| 2008 Q4 | -11.66 Million USD | -526.29% |
| 2008 Q3 | -1.86 Million USD | -163.92% |
| 2008 FY | -15.12 Million USD | -360.82% |
| 2008 Q1 | -892.58 Thousand USD | 32.35% |
| 2007 Q3 | 8.31 Million USD | 1880.82% |
| 2007 FY | 5.79 Million USD | 290.99% |
| 2007 Q4 | -1.31 Million USD | -115.86% |
| 2007 Q2 | -467.03 Thousand USD | 36.17% |
| 2007 Q1 | -731.72 Thousand USD | 32.05% |
| 2006 Q3 | -544.15 Thousand USD | 48.8% |
| 2006 Q1 | -352.33 Thousand USD | 71.53% |
| 2006 Q2 | -1.06 Million USD | -201.65% |
| 2006 Q4 | -1.07 Million USD | -97.9% |
| 2006 FY | -3.03 Million USD | -344.85% |
| 2005 Q4 | -1.23 Million USD | -249.51% |
| 2005 Q3 | 827.85 Thousand USD | 311.8% |
| 2005 Q2 | -390.87 Thousand USD | -418.91% |
| 2005 Q1 | 122.56 Thousand USD | -82.42% |
| 2005 FY | -682.51 Thousand USD | -120.92% |
| 2004 Q1 | 777.51 Thousand USD | -13.1% |
| 2004 Q4 | 697.26 Thousand USD | -15.64% |
| 2004 Q3 | 826.53 Thousand USD | -13.96% |
| 2004 Q2 | 960.62 Thousand USD | 23.55% |
| 2004 FY | 3.26 Million USD | 32.6% |
| 2003 Q1 | 450.97 Thousand USD | 2.84% |
| 2003 Q3 | 588.27 Thousand USD | 11.76% |
| 2003 FY | 2.46 Million USD | 38.08% |
| 2003 Q4 | 894.68 Thousand USD | 52.09% |
| 2003 Q2 | 526.38 Thousand USD | 16.72% |
| 2002 Q4 | 438.51 Thousand USD | -14.51% |
| 2002 FY | 1.78 Million USD | 7.27% |
| 2002 Q3 | 512.93 Thousand USD | 24.7% |
| 2002 Q2 | 411.32 Thousand USD | 41.48% |
| 2002 Q1 | 290.73 Thousand USD | -10.41% |
| 2001 FY | 1.66 Million USD | 189.85% |
| 2001 Q2 | 479.43 Thousand USD | 7.03% |
| 2001 Q1 | 447.92 Thousand USD | 367.27% |
| 2001 Q4 | 324.5 Thousand USD | -16.19% |
| 2001 Q3 | 387.2 Thousand USD | -19.24% |
| 2000 Q3 | -391.62 Thousand USD | 44.05% |
| 2000 Q2 | -700 Thousand USD | -75.0% |
| 2000 Q1 | -400 Thousand USD | -500.0% |
| 2000 FY | -1.84 Million USD | -716.22% |
| 2000 Q4 | -167.59 Thousand USD | 57.21% |
| 1999 Q4 | 100 Thousand USD | 111.11% |
| 1999 FY | 300 Thousand USD | 400.0% |
| 1999 Q1 | 100 Thousand USD | 0.0% |
| 1999 Q2 | 100 Thousand USD | 0.0% |
| 1999 Q3 | -900 Thousand USD | -1000.0% |
| 1998 Q3 | 100 Thousand USD | 200.0% |
| 1998 FY | -100 Thousand USD | 98.31% |
| 1998 Q4 | 100 Thousand USD | 0.0% |
| 1998 Q2 | -100 Thousand USD | 0.0% |
| 1998 Q1 | - USD | 100.0% |
| 1997 Q3 | -500 Thousand USD | 16.67% |
| 1997 Q4 | -4.4 Million USD | -780.0% |
| 1997 Q1 | -400 Thousand USD | 20.0% |
| 1997 FY | -5.9 Million USD | -37.21% |
| 1997 Q2 | -600 Thousand USD | -50.0% |
| 1996 Q4 | -500 Thousand USD | 75.0% |
| 1996 Q3 | -2 Million USD | -185.71% |
| 1996 Q2 | -700 Thousand USD | 22.22% |
| 1996 Q1 | -900 Thousand USD | 35.71% |
| 1996 FY | -4.3 Million USD | 6.52% |
| 1995 Q2 | -1.1 Million USD | 0.0% |
| 1995 FY | -4.6 Million USD | 26.98% |
| 1995 Q4 | -1.4 Million USD | -75.0% |
| 1995 Q3 | -800 Thousand USD | 27.27% |
| 1995 Q1 | -1.1 Million USD | 35.29% |
| 1994 Q2 | -1.6 Million USD | -33.33% |
| 1994 Q3 | -1.6 Million USD | 0.0% |
| 1994 Q1 | -1.2 Million USD | 0.0% |
| 1994 FY | -6.3 Million USD | -16.67% |
| 1994 Q4 | -1.7 Million USD | -6.25% |
| 1993 Q3 | -1.3 Million USD | 18.75% |
| 1993 FY | -5.4 Million USD | -35.0% |
| 1993 Q2 | -1.6 Million USD | -23.08% |
| 1993 Q4 | -1.2 Million USD | 7.69% |
| 1993 Q1 | -1.3 Million USD | 0.0% |
| 1992 FY | -4 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 61.91% |
| IR-Med Inc. | -4.91 Million USD | 97.873% |
| Polarean Imaging plc | -12.55 Million USD | 99.168% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 123.843% |
| Avitar, Inc. | 2.73 Million USD | 103.823% |
| AVITA Medical, Inc. | -40.4 Million USD | 99.741% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | 85.139% |
| Össur hf. | 87.46 Million USD | 100.119% |
| Zecotek Photonics Inc. | -3.65 Million USD | 97.143% |
| QHSLab, Inc. | -240.15 Thousand USD | 56.497% |
| Wellstar International, Inc. | -1.79 Million USD | 94.179% |
| Össur hf. | 87.46 Million USD | 100.119% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 105.02% |
| Aurora Spine Corporation | -446.19 Thousand USD | 76.585% |
| BrainsWay Ltd. | -4.92 Million USD | 97.88% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.45 Million USD | 98.896% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 137.582% |
| Vivos Inc. | -2.79 Million USD | 96.26% |
| MicroPort Scientific Corporation | -516.16 Million USD | 99.98% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | 56.317% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 94.103% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 72.427% |
| Nanomix Corporation | -8.43 Million USD | 98.762% |
| Theraclion SA | -3.48 Million USD | 96.999% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | 85.223% |
| Positron Corporation | -1.36 Million USD | 92.322% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | 94.94% |
| Lombard Medical, Inc. | -29.33 Million USD | 99.644% |
| ALR Technologies Inc. | -2.94 Million USD | 96.454% |
| Stratec SE | 25.26 Million USD | 100.413% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 359.949% |
| Heart Tronics, Inc. | 14.46 Million USD | 100.723% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | 13.317% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 99.496% |
| SANUWAVE Health, Inc. | -540 Thousand USD | 80.653% |
| VMS Rehab Systems, Inc. | -68.66 USD | -152064.288% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 96.978% |
| Ingen Technologies, Inc. | -1.61 Million USD | 93.525% |
| Odyssey Group International, Inc. | 14.26 Million USD | 100.733% |
| United American Healthcare Corporation | -67 Thousand USD | -55.934% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | 74.36% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | 83.539% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | 82.631% |
| Urologix, Inc. | -6.93 Million USD | 98.492% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | 91.73% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 98.332% |
| SS Innovations International, Inc. | -20.66 Million USD | 99.495% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | 54.623% |
| Smith & Nephew plc | 425 Million USD | 100.025% |
| NIOX Group Plc | 4.6 Million USD | 102.271% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 127.22% |
| Broncus Holding Corporation | -33.22 Million USD | 99.686% |
| Brain Scientific Inc. | -9.6 Million USD | 98.913% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 98.901% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -72.121% |